Drug developers look to lysine on disease-linked proteins
Covalent drugs gained steam by targeting cysteine on disease-related proteins. Now a second amino acid is in drug developers’ sights
Covalent drugs gained steam by targeting cysteine on disease-related proteins. Now a second amino acid is in drug developers’ sights